These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 7502227

  • 1. [The initial results on the radiobiological comparability of continuous LDR irradiation and PDR irradiation using a guinea pig skin animal model].
    Brock A, Prager W, Pohlmann S, Friedrich K.
    Strahlenther Onkol; 1995 Nov; 171(11):641-5. PubMed ID: 7502227
    [Abstract] [Full Text] [Related]

  • 2. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
    King CR.
    Brachytherapy; 2002 Nov; 1(4):219-26. PubMed ID: 15062170
    [Abstract] [Full Text] [Related]

  • 3. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F, Fowler JF, Leborgne JH, Zubizarreta E, Chappell R.
    Radiat Oncol Investig; 1997 Nov; 5(6):289-99. PubMed ID: 9436246
    [Abstract] [Full Text] [Related]

  • 4. [Radiobiological research to optimize high-dose-rate afterloading therapy with Ir-192 in extragenital tumors].
    Brock A, Pohlmann S, Prager W, Prager S.
    Strahlenther Onkol; 1992 Dec; 168(12):711-5. PubMed ID: 1481121
    [Abstract] [Full Text] [Related]

  • 5. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ, Horenblas S, Lebesque J, Moonen L, Schneider C, Sminia P, Bartelink H.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):696-705. PubMed ID: 15183473
    [Abstract] [Full Text] [Related]

  • 6. [Brachytherapy with pulsed dosage. General considerations. Radiobiological considerations. First clinical experience in Mestre (Venice)].
    Pizzi GB, Marchetti C.
    Radiol Med; 1997 Mar 01; 93(3):260-6. PubMed ID: 9221420
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
    Liu WS, Yen SH, Chang CH, Yang KM, Wu YP, Chen KY.
    Gynecol Oncol; 1996 Feb 01; 60(2):295-300. PubMed ID: 8631555
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The implementation of the Gynaecological Groupe Européen de Curiethérapie - European Society for Therapeutic Radiology and Oncology radiobiology considerations in the conversion of low dose rate to pulsed dose rate treatment schedules for gynaecological brachytherapy.
    Baker S, Pooler A, Hendry J, Davidson S.
    Clin Oncol (R Coll Radiol); 2013 Apr 01; 25(4):265-71. PubMed ID: 23218875
    [Abstract] [Full Text] [Related]

  • 11. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P, Dietrich J, Ostertag H, Schmid A, Kohr P, Kimmig B, Kovács G.
    Strahlenther Onkol; 2006 Feb 01; 182(2):102-7. PubMed ID: 16447017
    [Abstract] [Full Text] [Related]

  • 12. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E, Kim RY, Meleth S, De Los Santos J, Spencer S.
    Brachytherapy; 2006 Feb 01; 5(1):49-55. PubMed ID: 16563997
    [Abstract] [Full Text] [Related]

  • 13. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R, Nishimoto IN, Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1108-16. PubMed ID: 15990016
    [Abstract] [Full Text] [Related]

  • 14. Retrospective dosimetric comparison of low-dose-rate and pulsed-dose-rate intracavitary brachytherapy using a tandem and mini-ovoids.
    Mourtada F, Gifford KA, Berner PA, Horton JL, Price MJ, Lawyer AA, Eifel PJ.
    Med Dosim; 2007 Jul 15; 32(3):181-7. PubMed ID: 17707197
    [Abstract] [Full Text] [Related]

  • 15. [Pulse dose rate curietherapy].
    Mazeron JJ, Boisserie G, Baillet F.
    Bull Cancer Radiother; 1995 Jul 15; 82(3):332-5. PubMed ID: 8554884
    [Abstract] [Full Text] [Related]

  • 16. [The dosage-performance effects on Ca-Ski and HPK cells in relation to the dose and fractionation].
    Schulz-Wendtland R, Krämer S, Keilholz L, Pflüger S, Lang N.
    Strahlenther Onkol; 1996 Aug 15; 172(8):439-45. PubMed ID: 8765347
    [Abstract] [Full Text] [Related]

  • 17. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments.
    Visser AG, van den Aardweg GJ, Levendag PC.
    Int J Radiat Oncol Biol Phys; 1996 Jan 15; 34(2):497-505. PubMed ID: 8567354
    [Abstract] [Full Text] [Related]

  • 18. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):489-95. PubMed ID: 16246495
    [Abstract] [Full Text] [Related]

  • 19. Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures.
    Mitchell CR, Joiner MC.
    Int J Radiat Biol; 2002 Nov 01; 78(11):981-90. PubMed ID: 12456285
    [Abstract] [Full Text] [Related]

  • 20. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS, Martinez AA, Hollander M, Huang R, Goldman K, Chen PY, Gustafson GS.
    J Urol; 2004 Mar 01; 171(3):1098-104. PubMed ID: 14767279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.